Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-452-625"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"sk"^^xsd:language2
lpv:document identification number	"en.20120911.32.2-452-625"2
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-452-6872
lpv:speaker	lp:Monika Beňová2
lpv:spokenAs	unknown; SMER-Sociálna demokracia (2009-07-14--2014-06-30)3 member; Delegation for relations with Israel (2009-09-16--2014-06-30)3 member; S&D (2012-01-19--2014-06-30)3 substitute; AFET (2012-01-19--2014-06-30)3 member; CRIM (2012-03-28--2013-10-23)3 member; LIBE (2012-01-19--2014-06-30)3
lpv:translated text	"Donated tissues and cells, such as skin, bones, tendons, corneas and haematopoietic stem cells, are increasingly used in medical therapies and as starting material for advanced therapy medicinal products. Directive 2004/23/EC states that Member States shall endeavour to ensure voluntary and unpaid donations of tissues and cells and that the procurement of tissues and cells shall be carried out on a non-profit basis. There is, then, a clear statutory obligation to proceed in this way. Donations should be voluntary and carried out on a non-profit basis in a transparent environment. As health care is largely a Member State competency, the recommendations set forth are geared to complement existing practices in Member States and build primarily on areas such as cross-border donation. The report works towards increasing tissue and cell supply by exchanging best practice in relation to common operations, ethical standards and raising awareness of donation. To aid effective cross-border cooperation in this area, robust checks should be carried out to ensure maximum traceability and transparency in the donation system."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph